Is Procter & Gamble stock a Buy, Sell or Hold?
Procter & Gamble stock has received a consensus rating of buy. The average rating score is Aa3 and is based on 38 buy ratings, 12 hold ratings, and 0 sell ratings.What was the 52-week low for Procter & Gamble stock?
The low in the last 52 weeks of Procter & Gamble stock was 122.18. According to the current price, Procter & Gamble is 116.98% away from the 52-week low.What was the 52-week high for Procter & Gamble stock?
The high in the last 52 weeks of Procter & Gamble stock was 164.90. According to the current price, Procter & Gamble is 86.68% away from the 52-week high.What are analysts forecasts for Procter & Gamble stock?
The 50 analysts offering price forecasts for Procter & Gamble have a median target of 158.76, with a high estimate of 180.00 and a low estimate of 130.00. The median estimate represents a 90.03 difference from the last price of 142.93.Procter & Gamble Stock Snapshot
142.88
Bid
15,100.00
Bid Size
142.89
Ask
20,500.00
Ask Size
3/17/2023
Date
4:15 PM
Time
8.73 M
Volume
142.89
Prev. Close
142.83
Open
334.75 B
Market Cap
2.36 B
Number of Shares
141.55
Day Low
143.39
Day High
142.93
122.18
52 Week Low
164.90
52 Week High
142.93
3.71
Dividend
2.66
Dividend Yield
24.68
P/E Ratio
99.91
Free Float in %
5.83
EPS 2023
21.09
Book Value per Share
6.58
Cash Flow per Share
Procter & Gamble News More News
Procter & Gamble Historical Prices
| Date | Open | Close | Daily High | Daily Low |
|---|
Price change over selected period:
0%
0
Procter & Gamble Analyst Data
Total Analysts: 50
Analyst: {{ANALYST_DATA}}
Price-Target: {{PRICE_DATA}}
Rating: {{RATING_DATA}}
Price-Target: {{PRICE_DATA}}
Rating: {{RATING_DATA}}
Price
*Price Target
Lowest: 130.00
Median: 158.76
Highest: 180.00
*The average price target includes all analyst analysis, not just the most recent analysis presented in the chart.
Procter & Gamble Analyst Opinions
- All
- Buy
- Hold
- Sell
| 03/03/23 | J.P. Morgan | Upgraded to Buy | $155 | ||
| 03/01/23 | UBS | Upgraded to Buy | $163 | ||
| 02/17/23 | Citigroup Corp. | Maintained Buy | $160 | ||
| 01/23/23 | Barclays Capital | Maintained Buy | $158 | ||
| 01/20/23 | Stifel, Nicolaus & Co., Inc. | Maintained Buy | $147 | ||
| 01/20/23 | Wells Fargo & Co | Maintained Buy | $162 | ||
| 01/13/23 | J.P. Morgan | Maintained Hold | $150 | ||
| 01/13/23 | Raymond James Financial, Inc. | Maintained Buy | $170 | ||
| 01/03/23 | Wells Fargo & Co | Maintained Buy | $168 | ||
| 12/06/22 | Deutsche Bank | Maintained Buy | $162 | ||
| 11/22/22 | Wolfe Research | Maintained Buy | $156 | ||
| 11/21/22 | Raymond James Financial, Inc. | Maintained Buy | $165 | ||
| 11/16/22 | Wells Fargo & Co | Maintained Buy | $155 | ||
| 11/15/22 | Credit Suisse | Maintained Hold | $130 | ||
| 10/20/22 | Barclays Capital | Maintained Buy | $145 | ||
| 10/20/22 | Deutsche Bank | Maintained Buy | $156 | ||
| 10/14/22 | Credit Suisse | Maintained Hold | $140 | ||
| 10/13/22 | J.P. Morgan | Maintained Hold | $140 | ||
| 10/12/22 | Raymond James Financial, Inc. | Maintained Buy | $155 | ||
| 10/10/22 | Deutsche Bank | Maintained Buy | $155 | ||
| 10/10/22 | Goldman Sachs | Downgraded to Hold | |||
| 10/04/22 | Morgan Stanley | Maintained Buy | $160 | ||
| 10/03/22 | Wells Fargo & Co | Maintained Buy | $150 | ||
| 08/02/22 | Barclays Capital | Maintained Buy | $154 | ||
| 07/25/22 | Raymond James Financial, Inc. | Maintained Buy | $175 | ||
| 07/21/22 | J.P. Morgan | Maintained Hold | $156 | ||
| 06/21/22 | Deutsche Bank | Maintained Buy | $157 | ||
| 06/01/22 | Deutsche Bank | Maintained Buy | $171 | ||
| 06/01/22 | Wells Fargo & Co | Maintained Buy | $170 | ||
| 05/23/22 | Barclays Capital | Maintained Buy | $157 | ||
| 04/22/22 | Barclays Capital | Maintained Buy | $176 | ||
| 04/21/22 | Deutsche Bank | Maintained Buy | $177 | ||
| 04/21/22 | Raymond James Financial, Inc. | Maintained Buy | $180 | ||
| 04/21/22 | Credit Suisse | Maintained Hold | $150 | ||
| 04/08/22 | Raymond James Financial, Inc. | Maintained Buy | $175 | ||
| 04/01/22 | Barclays Capital | Maintained Buy | $167 | ||
| 03/30/22 | J.P. Morgan | Downgraded to Hold | $165 | ||
| 03/16/22 | Deutsche Bank | Maintained Buy | $173 | ||
| 01/20/22 | RBC Capital Markets | Maintained Hold | $160 | ||
| 01/20/22 | Deutsche Bank | Maintained Buy | $179 | ||
| 01/20/22 | Morgan Stanley | Maintained Buy | $177 | ||
| 10/04/21 | Deutsche Bank | Maintained Buy | $163 | ||
| 09/07/21 | Morgan Stanley | Maintained Buy | $161 | ||
| 08/02/21 | Morgan Stanley | Maintained Buy | $160 | ||
| 08/02/21 | RBC Capital Markets | Maintained Hold | $139 | ||
| 08/02/21 | Credit Suisse | Maintained Hold | $145 | ||
| 06/24/21 | UBS | Maintained Hold | $138 | ||
| 04/21/21 | Deutsche Bank | Maintained Buy | $158 | ||
| 04/21/21 | Citigroup Corp. | Downgraded to Hold | $150 | ||
| 04/19/21 | Morgan Stanley | Maintained Buy | $155 |
Procter & Gamble Estimates* in USD
| 2023 | 2024 | 2025 | 2026 | 2027 | |
|---|---|---|---|---|---|
| Revenue | 80,746 | 84,128 | 87,785 | 92,658 | 95,019 |
| Dividend | 3.71 | 3.91 | 4.09 | 4.32 | 4.35 |
| Dividend Yield (in %) | 2.66 % | 2.80 % | 2.93 % | 3.09 % | 3.12 % |
| EPS | 5.83 | 6.31 | 6.89 | 7.67 | 7.64 |
| P/E Ratio | 24.69 | 22.83 | 20.91 | 18.78 | 18.84 |
| EBIT | 18,057 | 19,350 | 20,777 | 22,636 | 23,097 |
| EBITDA | 20,830 | 22,389 | 24,122 | 26,270 | 26,703 |
| Net Profit | 14,513 | 15,480 | 16,606 | 17,815 | 18,922 |
| Net Profit Adjusted | 14,476 | 15,478 | 16,622 | 17,815 | 18,922 |
| Pre-Tax Profit | 18,195 | 19,382 | 20,794 | 22,112 | 22,622 |
| Net Profit (Adjusted) | 18,150 | 19,299 | 20,683 | 22,396 | 23,415 |
| EPS (Non-GAAP) ex. SOE | 5.83 | 6.31 | 6.89 | 7.67 | 7.64 |
| EPS (GAAP) | 5.90 | 6.36 | 6.87 | 7.20 | 7.64 |
| Gross Income | 38,092 | 40,516 | 43,366 | - | - |
| Cash Flow from Investing | -3,452 | -3,911 | -4,080 | -4,553 | -4,751 |
| Cash Flow from Operations | 17,013 | 19,020 | 20,514 | 22,415 | 23,506 |
| Cash Flow from Financing | -12,907 | -14,721 | -14,675 | -22,426 | -22,829 |
| Cash Flow per Share | 6.58 | 7.46 | 7.91 | 6.78 | - |
| Free Cash Flow | 13,275 | 14,949 | 16,224 | 17,016 | 18,755 |
| Free Cash Flow per Share | 5.42 | 6.35 | 6.73 | - | - |
| Book Value per Share | 21.09 | 22.62 | 21.61 | 23.68 | - |
| Net Debt | 26,893 | 27,498 | 27,301 | 27,117 | - |
| Research & Development Exp. | 2,274 | 2,379 | 2,658 | - | - |
| Capital Expenditure | 3,702 | 3,936 | 4,105 | 4,238 | 4,198 |
| Selling, General & Admin. Exp. | 19,912 | 20,829 | 21,863 | - | - |
| Shareholder’s Equity | 47,007 | 46,867 | 47,452 | 44,418 | 44,400 |
| Total Assets | 118,191 | 120,376 | 123,522 | 110,658 | 109,269 |
| Previous Quarter | Current Quarter |
Next Quarter ending 06/30/23 |
Current Year ending 06/30/23 |
Next Year ending 06/30/24 |
|
|---|---|---|---|---|---|
| Earnings Estimates | |||||
| No. of Analysts | - | - | 20 | 23 | 23 |
| Average Estimate | - | - | 1.346 USD | 5.831 USD | 6.305 USD |
| Year Ago | - | - | 1.210 USD | 5.810 USD | 5.831 USD |
| Publish Date | - | - | 1/19/2023 | - | - |
| Revenue Estimates | |||||
| No. of Analysts | - | - | 15 | 20 | 20 |
| Average Estimate | - | - | 19,784 USD | 80,746 USD | 84,128 USD |
| Year Ago | - | - | 19,515 USD | 80,187 USD | 80,746 USD |
| Publish Date | - | - | 1/19/2023 | - | - |
* Average Estimates in Million (e.g. Revenue) or per share (e.g. Dividend). Source: FactSet
Procter & Gamble Insider Activity
| Name | Date | shares traded | shares held | Price | type (sell/buy) | option |
|---|---|---|---|---|---|---|
| JIMENEZ JOSEPH | 03/13/2023 | 287.00 | 27,275.01 | n/a | Buy | No |
| Allen Bertrand Marc | 03/13/2023 | 179.00 | 4,872.95 | n/a | Buy | No |
| McCarthy Christine M | 03/13/2023 | 179.00 | 9,268.37 | n/a | Buy | No |
| Braly Angela F | 03/13/2023 | 215.00 | 53,700.75 | n/a | Buy | No |
| Kempczinski Christopher J | 03/13/2023 | 179.00 | 4,095.22 | n/a | Buy | No |
| WOERTZ PATRICIA A | 03/13/2023 | 233.00 | 43,840.63 | n/a | Buy | No |
| LUNDGREN TERRY J | 03/13/2023 | 224.00 | 35,996.77 | n/a | Buy | No |
| Whaley Susan Street | 02/28/2023 | 709.00 | 10,197.66 | 137.34 | Sell | No |
| Janzaruk Matthew W. | 02/28/2023 | 160.00 | 1,157.57 | 137.34 | Sell | No |
| Schulten Andre | 02/28/2023 | 1,311.00 | 35,142.00 | 137.34 | Sell | No |
| Moeller Jon R | 02/28/2023 | 164.00 | 35,221.57 | 137.34 | Sell | No |
| Moeller Jon R | 02/28/2023 | 2,151.00 | 226,747.91 | 137.34 | Sell | No |
| Purushothaman Balaji | 02/28/2023 | 695.00 | 13,001.42 | 137.34 | Sell | No |
| Keith R. Alexandra | 02/28/2023 | 1,194.00 | 7,553.02 | 137.34 | Sell | No |
| Keith R. Alexandra | 02/28/2023 | 5,349.00 | 34,149.94 | 137.34 | Sell | No |
| Whaley Susan Street | 02/02/2023 | 435.00 | 10,839.76 | 141.82 | Sell | No |
| WOERTZ PATRICIA A | 12/12/2022 | 247.00 | 43,333.22 | n/a | Buy | No |
| JIMENEZ JOSEPH | 12/12/2022 | 292.00 | 26,893.02 | n/a | Buy | No |
| Kempczinski Christopher J | 12/12/2022 | 198.00 | 3,890.60 | n/a | Buy | No |
| Allen Bertrand Marc | 12/12/2022 | 198.00 | 4,663.24 | n/a | Buy | No |
| Braly Angela F | 12/12/2022 | 230.00 | 53,135.80 | n/a | Buy | No |
| McCarthy Christine M | 12/12/2022 | 198.00 | 9,029.91 | n/a | Buy | No |
| LUNDGREN TERRY J | 12/12/2022 | 239.00 | 35,547.05 | n/a | Buy | No |
| Jejurikar Shailesh | 12/06/2022 | 122.79 | 9,948.10 | 149.18 | Sell | No |
| Jejurikar Shailesh | 12/06/2022 | 43.55 | 10,070.89 | 149.18 | Sell | No |
Procter & Gamble Dividend Calendar
| Date | Name | Dividend | *yield | Currency |
|---|---|---|---|---|
| 2022 | Procter & Gamble Co. | 3.52 | 2.45 | USD |
| 2021 | Procter & Gamble Co. | 3.24 | 2.40 | USD |
| 2020 | Procter & Gamble Co. | 3.03 | 2.53 | USD |
| 2019 | Procter & Gamble Co. | 2.90 | 2.64 | USD |
| 2018 | Procter & Gamble Co. | 2.79 | 3.57 | USD |
| 2017 | Procter & Gamble Co. | 2.70 | 3.10 | USD |
| 2016 | Procter & Gamble Co. | 2.66 | 3.14 | USD |
| 2015 | Procter & Gamble Co. | 2.59 | 3.31 | USD |
| 2015 | Procter & Gamble Co. | 2.59 | 3.32 | USD |
| 2014 | Procter & Gamble Co. | 2.45 | 3.12 | USD |
| 2013 | Procter & Gamble Co. | 2.29 | 2.97 | USD |
| 2012 | Procter & Gamble Co. | 2.14 | 3.49 | USD |
| 2011 | Procter & Gamble Co. | 1.97 | 3.10 | USD |
| 2010 | Procter & Gamble Co. | 1.80 | 3.00 | USD |
| 2009 | Procter & Gamble Co. | 1.64 | 3.21 | USD |
| 2008 | Procter & Gamble Co. | 1.45 | 2.38 | USD |
| 2007 | Procter & Gamble Co. | 1.28 | 2.09 | USD |
| 2006 | Procter & Gamble Co. | 1.15 | 2.07 | USD |
| 2005 | Procter & Gamble Co. | 1.03 | 1.86 | USD |
| 2004 | Procter & Gamble Co. | 0.93 | 1.72 | USD |
| 2003 | Procter & Gamble Co. | 0.82 | 1.84 | USD |
| 2002 | Procter & Gamble Co. | 0.76 | 1.70 | USD |
| 2001 | Procter & Gamble Co. | 0.70 | 2.19 | USD |
| 2000 | Procter & Gamble Co. | 0.64 | 2.26 | USD |
| 1999 | Procter & Gamble Co. | 0.57 | 1.29 | USD |
*Yield of the Respective Date
Procter & Gamble Co. Calendar
| Event | Estimate | Info | Date |
|---|---|---|---|
| Earnings Report | - | Q3 2023 Earnings Release | 04/20/2023 |
| Press Conference | - | 04/21/2023 | |
| Earnings Report | - | Q4 2023 Earnings Release | 07/28/2023 |
| Earnings Report | - | Q1 2024 Earnings Release | 10/20/2023 |
| Earnings Report | - | Q2 2024 Earnings Release | 01/17/2024 |
| Earnings Report | - | Q3 2024 Earnings Release | 04/18/2024 |
| Earnings Report | - | Q4 2024 Earnings Release | 07/26/2024 |
Procter & Gamble Co. Past Events
| Event | Actual EPS | Info | Date |
|---|---|---|---|
| Earnings Report | 1.210 USD | Q2 2023 Earnings Release | 01/19/2023 |
| Press Conference | - | - | 01/19/2023 |
| Shareholders' Meeting | - | - | 10/11/2022 |
| Press Conference | - | - | 07/29/2022 |
| Press Conference | - | - | 04/20/2022 |
Procter & Gamble Profile
Procter & Gamble Co. engages in the provision of branded consumer packaged goods. It operates through the following segments: Beauty, Grooming, Health Care, Fabric & Home Care, and Baby, Feminine & Family Care. The Beauty segment offers hair, skin, and personal care. The Grooming segment consists of shave care like female and male blades and razors, pre and post shave products, and appliances. The Health Care segment includes oral care products like toothbrushes, toothpaste, and personal health care such as gastrointestinal, rapid diagnostics, respiratory, and vitamins, minerals, and supplements. The Fabric and Home care segment consists of fabric enhancers, laundry additives and detergents, and air, dish, and surface care. The Baby, Feminine and Family Care segment sells baby wipes, diapers, and pants, adult incontinence, feminine care, paper towels, tissues, and toilet paper.
Moody’s Daily Credit Risk Score
Procter & Gamble Shareholder
| Owner | in % |
|---|---|
| Freefloat | 99.91 |
| Vanguard Group, Inc. (Subfiler) | 9.14 |
| State Street Corp. | 4.47 |
| Vanguard Total Stock Market Index Fund | 3.09 |
| BlackRock Fund Advisors | 2.49 |
| Vanguard 500 Index Fund | 2.33 |
| BlackRock Institutional Trust Co. NA | 2.20 |
| Geode Capital Management LLC | 1.96 |
| Wellington Management Co. LLP | 1.41 |
| Fidelity 500 Index Fund | 1.10 |
| SPDR S&P 500 ETF Trust | 1.08 |
| Norges Bank (13F) | 1.05 |
| Government Pension Fund - Global (The) | 1.03 |
| Morgan Stanley Smith Barney LLC | 0.81 |
| Northern Trust Investments, Inc.(Investment Management) | 0.76 |
Shareholder percentage totals can add to more than 100% because some holders are included in the free float.
Procter & Gamble Management
| Name | Job |
|---|---|
| Jon R. Moeller | Chairman, President & Chief Executive Officer |
| Matthew W. Janzaruk | Chief Accounting Officer & Senior Vice President |
| Kirti Singh | Chief Analytics & Insights Officer |
| Marc S. Pritchard | Chief Brand Officer |
| Damon Jones | Chief Communications Officer |
| Philip J. Duncan | Chief Design Officer |
| Shelly McNamara | Chief Equality & Inclusion Officer |
| Ken K. Patel | Chief Ethics & Compliance Officer |
| Fatima Francisco | Chief Executive Officer-Baby & Feminine Care |
| R. Alexandra Keith | Chief Executive Officer-Beauty |
| Carolyn M. Tastad | Chief Executive Officer-Health Care |
| Andre Schulten | Chief Financial Officer |
| Mary Theresa Grabowski | Chief Human Resources Officer |
| Vittorio Cretella | Chief Information Officer |
| Shailesh G. Jejurikar | Chief Operating Officer |
| Julio N. Nemeth | Chief Product Supply Officer |
| Victor Aguilar | Chief Research, Development & Innovation Officer |
| Mindy Sherwood | Chief Sales Officer & President-Global Walmart |
| Virginie Helias | Chief Sustainability Officer |
| Debra L. Lee | Independent Director |
| Terry J. Lundgren | Independent Director |
| Angela F. Braly | Independent Director |
| Bertrand-Marc Allen | Independent Director |
| Christopher J. Kempczinski | Independent Director |
| Patricia Ann Woertz | Independent Director |
| Amy L. Chang | Independent Director |
| Christine M. McCarthy | Independent Director |
| Rajesh Subramaniam | Independent Director |
| John T. Chevalier | Investor Relations Contact |
| Joseph Jimenez | Lead Independent Director |
| Ivy Ross | Member-Design Board |
| Magesvaran Suranjan | President-Asia Pacific Selling & Market Operations |
| Monica Turner | President-North America |
| Deborah Platt Majoras | Secretary & Chief Legal Officer |
| Namrata P Patel | Senior Vice President-Product Supply |